Transforming Heart Health with Cleerly: AI-Powered Innovations in Cardiac Care

Transforming Heart Health with Cleerly: AI-Powered Innovations in Cardiac Care

Heart disease remains a leading cause of death worldwide, often catching individuals off guard. With more than half of heart attack victims showing no prior symptoms, the need for proactive, personalized care has never been more critical. Cleerly , under the leadership of Dr. Jim Min, we are revolutionizing the way we approach cardiac health using advanced AI and imaging technologies.

The Unseen Enemy: Silent Heart Disease

Heart disease often operates in silence, with 51% of heart attack victims reporting no symptoms prior to their event. Dr. Min emphasized this alarming statistic, sharing how Cleerly’s approach aims to identify at-risk individuals early. By leveraging AI-powered imaging, Cleerly enables healthcare providers to uncover hidden risks, transforming what was once invisible into actionable insights.

“We’ve found that imaging allows us to see the plaques within the walls of arteries—plaques that tell us who is at risk for a heart attack,” Dr. Min explained. “This gives us a chance to intervene long before catastrophic events occur.”

AI at the Core of Cleerly’s Mission

Cleerly’s technology employs end-to-end AI algorithms to evaluate cardiac health comprehensively. These tools analyze image quality, segment arteries, and predict ischemia (reduced blood flow), among other capabilities. This precision empowers doctors with quick, accurate insights that can seamlessly integrate into their workflows.

“As a cardiologist, if I wait for patients to come to me, many won’t,” Dr. Min said. “AI enables us to bring heart disease screening directly into the home, much like mammograms or colonoscopies.”

Personalized Care for Every Patient

One of Cleerly’s core philosophies is shifting from treating patients as statistics to seeing them as individuals. Their solutions cater to both asymptomatic individuals and those presenting with symptoms like chest pain. For symptomatic patients, Cleerly Ischemia provides unparalleled accuracy in diagnosing whether symptoms are related to heart disease.

Cleerly’s imaging-guided approach serves as a game-changer for asymptomatic individuals, offering the potential to screen populations and address risks before symptoms arise.

Success Stories: Saving Lives Through Technology

Dr. Min shared a powerful anecdote involving Lance Armstrong, who used Cleerly’s analysis to better understand his heart health. “He found he was healthy and didn’t need lifelong medication,” Dr. Min recalled.

Cleerly’s Hero’s Heart program further illustrates its impact, focusing on firefighters who face early onset of heart disease. “Even identifying one at-risk individual can profoundly change their life,” Dr. Min said.

Breaking Down Barriers in Cardiac Care

Cleerly’s tools are now more accessible than ever, thanks to Medicare and commercial insurance coverage. Their efforts also include making AI results understandable and actionable for clinicians.

“Our goal is to support doctors with data that is easy to interpret and integrate into their existing systems,” Dr. Min said.

Looking Ahead: The Future of Cardiac Care

Cleerly’s vision extends far beyond immediate diagnosis and treatment. The company is engaged in a 7,500-patient clinical trial to prove that image-based, AI-enabled diagnostics outperform traditional methods in improving health outcomes.

“Our legacy tools don’t work as well as they should,” Dr. Min stated. “We’re committed to developing evidence that shows personalized imaging can save lives.”

Join the Movement

Cleerly’s groundbreaking work is redefining what’s possible in cardiac care. To learn more or access their services, visit Cleerly Health.